All Stories

  1. Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasis
  2. Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI)
  3. Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to date
  4. Anti-IL17 therapies for psoriasis
  5. Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
  6. Successful treatment of atopic dermatitis with the JAK1 inhibitor oclacitinib
  7. Systematic review of the real-world evidence of adalimumab safety in psoriasis registries
  8. No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate-to-severe plaque psoriasis
  9. Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
  10. A congenital naevus in a blaschkoid distribution
  11. Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory Conditions
  12. A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis
  13. Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature
  14. Observations from our evaluation of bodyweight changes after initiation of a biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
  15. Quality of life instruments in psoriasis clinical trials
  16. Developing more open and equitable relationships with industry to improve advancements in clinical research in dermatology
  17. Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
  18. Palmoplantar pustular psoriasis unresponsive to the interleukin-1β antagonist canakinumab
  19. Treatment of two patients with generalized pustular psoriasis with the interleukin-1β inhibitor gevokizumab
  20. Successful treatment of generalized granuloma annulare with adalimumab
  21. Nodular fasciitis of the lip mucosa: a rare but clinically important entity
  22. The prevalence of Dupuytren contractures in patients with psoriasis
  23. Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis